Randomized phase II trial of hydroxychloroquine in combination with gemcitabine/nab-paclitaxel to inhibit autophagy in pancreatic cancer: A SU2C-funded trial Meeting Abstract


Authors: Karasic, T. B.; O'Hara, M. H.; Loaiza-Bonilla, A.; Reiss-Binder, K. A.; Teitelbaum, U. R.; Borazanci, E.; De Jesus-Acosta, A. M.; Redlinger, C.; Burrell, J. A.; Von Hoff, D. D.; Laheru, D. A.; Amaravadi, R. K.; Drebin, J. A.; O'Dwyer, P. J.
Abstract Title: Randomized phase II trial of hydroxychloroquine in combination with gemcitabine/nab-paclitaxel to inhibit autophagy in pancreatic cancer: A SU2C-funded trial
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468818900078
DOI: 10.1158/1538-7445.Am2018-ct085
PROVIDER: wos
Notes: Meeting Abstract: CT085 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jeffrey Adam Drebin
    165 Drebin